XML Financial, LLC: OLED position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of XML Financial, LLC on OLED, newest first. How the timeline and the estimate are built.
XML Financial, LLC held 0 OLED shares at 2025-12-31 per its 13F-HR filed 2026-02-11.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -2,587 shares
13F-HR 0001725547-26-000074 filed by XML Financial, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 2,587 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $371,571.
13F-HR 0001725547-25-004125 filed by XML Financial, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,587 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $399,588.
13F-HR 0001725547-25-003469 filed by XML Financial, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,587 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $360,835.
13F-HR 0001725547-25-001441 filed by XML Financial, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 2,587 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $378,219.
13F-HR 0001725547-25-000138 filed by XML Financial, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 2,587 sharesChange vs previous 13F not available
0.05% of the 13F portfolio, value $543,011.
13F-HR 0001725547-24-006074 filed by XML Financial, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).